Skip to main content

Retransplantation: is the trouble worth the effort?

  • Chapter
Retransplantation

Part of the book series: Transplantation and Clinical Immunology ((TRAC,volume 29))

  • 92 Accesses

Abstract

The merits of retransplantation have often been debated [115]. Opponents are of the opinion that patients who have not had a previous transplant should be given a fair opportunity to receive one. Proponents of retransplantation argue that organs should be allocated based on medical urgency. They believe that patients awaiting their first graft stand a reasonable chance of receiving a donor organ at a later date. A retransplant candidate often has a diminished probability of survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stratta RJ, Oh CS, Sollinger HW, Pirsch JD, Kalayoglu M, Beizer FO. Kidney retransplantation in the cyclosporine era. Transplantation 1988; 45: 40–45.

    Article  PubMed  CAS  Google Scholar 

  2. Dein JR, Oyer PE, Stinson EB, Starnes VA, Shumway NE. Cardiac retransplantation in the cyclosporine era. Ann. Thorac. Surg. 1989; 48: 350–355.

    Article  PubMed  CAS  Google Scholar 

  3. Salmela K, Kyllonen L, Eklund B, Isoniemi H, Hockerstedt K, Ahonen J. The value of repeated renal transplantation. Transplantation 1990; 50: 984–986.

    Article  PubMed  CAS  Google Scholar 

  4. Gordon RD, Hartner CM, Casavilla A et al. The liver transplant waiting list-a single-center analysis. Transplantation 1991; 51: 128–134.

    Article  PubMed  CAS  Google Scholar 

  5. Mora NP, Klintmalm GB, Cofer JB et al. Results after liver retransplantation in a group of 50 regrafted patients: two different concepts of elective versus emergency retransplantation. Transplant. Int. 1991; 4: 231–234.

    Article  CAS  Google Scholar 

  6. Candinas D, Keusch G, Conrad B, Schlumpf R, Decurtins M, Largiader F. A 20-year follow-up of cadaveric kidney allotransplantation. Transplant Proc. 1992; 24: 2711–2713.

    PubMed  CAS  Google Scholar 

  7. Ensley RD, Hunt S, Taylor DO et al. Predictors of survival after repeat heart transplantation. The Registry of the International Society for Heart and Lung Transplantation, and Contributing Investigators. J. Heart Lung Transplant. 1992; 11: S142–S158.

    PubMed  CAS  Google Scholar 

  8. Karwande SV, Ensley RD, Renlund DG et al. Cardiac retransplantation: a viable option? The Registry of the International Society for Heart and Lung Transplantation. Ann. Thorac. Surg. 1992; 54: 840–844.

    Article  PubMed  CAS  Google Scholar 

  9. Retransplantation termed unfair, cost-ineffective. UNOS Update 1992; 8: 4.

    Google Scholar 

  10. Evans RW. A cost-outcome analysis of retransplantation: the need for accountability. Transplant. Rev. 1993; 7: 163–175.

    Article  Google Scholar 

  11. Evans RW. Is retransplantation cost-effective? Transplant. Proc. 1993; 25: 1694–1696.

    PubMed  CAS  Google Scholar 

  12. Michler RE, Edwards NM, Hsu D et al. Pediatric retransplantation. J. Heart Lung Transplant. 1993; 12: S319–S327.

    PubMed  CAS  Google Scholar 

  13. Michler RE, McLaughlin MJ, Chen JM et al. Clinical experience with cardiac retransplantation. J. Thorac. Cardiovasc. Surg. 1993; 106: 622–631.

    PubMed  CAS  Google Scholar 

  14. Mentzer SJ, Reilly JJ, Caplan AL, Sugarbaker DJ. Ethical considerations in lung retransplanta-tion. J. Heart Lung Transplant. 1994; 13: 56–58.

    PubMed  CAS  Google Scholar 

  15. Smith JR, Ribakove GH, Hunt SA et al. Heart retransplantation: the 25-year experience at a single institution. J. Heart Lung Transplant. 1995; 14: 832–839.

    PubMed  CAS  Google Scholar 

  16. Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation: costs, insurance coverage, and reimbursement. Gastroenterol Clin. North Am. 1993; 22: 451–473.

    PubMed  CAS  Google Scholar 

  17. Evans RW. Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit. In: Terasaki PI, Cecka JM (eds.), Clinical Transplants, 1993. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1994: 359–391.

    Google Scholar 

  18. Evans RW. Liver transplantation in a managed care environment. Liver Transplant. Surg. 1995; 1: 61–75.

    Article  CAS  Google Scholar 

  19. Evans RW. Organ transplantation in an era of economic constraint: liver transplantation as a case study. Semin. Anesthesiol. 1995; 14: 127–135.

    Google Scholar 

  20. Evans RW. Socioeconomic aspects of heart transplantation. Curr. Opin. Cardiol. 1995; 10: 169–179.

    Article  PubMed  CAS  Google Scholar 

  21. Evans RW. Effect of liver transplantation on local, regional, and national health care. In: Busuttil RW, Klintmalm GB (eds.), Transplantation of the Liver. Philadelphia,PA: W.B. Saunders, 1996: 869–879.

    Google Scholar 

  22. Evans RW, Kitzmann DJ. Contracting for services: liver transplantation in the era of mismanaged care. Clinics in Liver Disease 1997; 1: (in press).

    Google Scholar 

  23. Evans RW, Kitzmann D. The ‘arithmetic’ of donor liver allocation. In: Terasaki PI, Cecka JM (eds.), Clinical Transplants, 1996. Los Angeles,CA: UCLA Tissue Typing Laboratory, 1997.

    Google Scholar 

  24. Hauboldt RH. Cost Implications of Human Organ Transplantations, An Update: 1993. Brookfield, WI: Milliman and Robertson, Inc., 1993.

    Google Scholar 

  25. Hauboldt RH. Cost Implications of Human Organ and Tissue Transplantation, An Update: 1996. Brookfield,WI: Milliman & Robertson, 1996.

    Google Scholar 

  26. Relman AS. Assessment and accountability; the third revolution in medical care. N. Engl. J. Med. 1988; 319: 1220–1222.

    Article  PubMed  CAS  Google Scholar 

  27. Lohr KN. Outcome measurement; concepts and questions. Inquiry 1988; 25: 37–50.

    PubMed  CAS  Google Scholar 

  28. Epstein AM. The outcomes movement — will it get us where we want to go? N. Engl. J. Med. 1990; 323: 266–270.

    Article  PubMed  CAS  Google Scholar 

  29. Geigle R, Jones SB. Outcomes measurement: a report from the front. Inquiry 1990; 27: 7–13.

    PubMed  CAS  Google Scholar 

  30. Hopkins A, Costain D. Measuring the Outcomes of Medical Care. London, England: Royal College of Physicians of London, 1990.

    Google Scholar 

  31. Clinton JJ. Outcomes research — a way to improve medical practice. JAMA 1991; 266: 2057.

    Article  PubMed  CAS  Google Scholar 

  32. Delamothe T. Outcomes into Clinical Practice. London: BMJ Publishing, 1994.

    Google Scholar 

  33. Guadagnoli E, McNeil BJ. Outcomes research: hope for the future or the latest rage? Inquiry 1994; 31: 14–24.

    PubMed  CAS  Google Scholar 

  34. Dauphinee WD. Assessing clinical performance: where do we stand and what might we expect? JAMA 1995; 274: 741–743.

    Article  PubMed  CAS  Google Scholar 

  35. Hayward J. Promoting clinical effectiveness. Br. Med. J. 1996; 312: 1491–1492.

    CAS  Google Scholar 

  36. Evans RW. A critical perspective on the tools to support clinical decision making (editorial). Transfusion 1996; 36: 671–673.

    Article  PubMed  CAS  Google Scholar 

  37. Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network — Transplant Data. Richmond, VA: UNOS and the U.S. Department of Health and Human Services, 1996.

    Google Scholar 

  38. Evans RW, Manninen DL, Dong FB. The National Cooperative Transplantation Study: Final Report. Seattle, WA: Battelle-Seattle Research Center, 1991.

    Google Scholar 

  39. Evans RW. Executive Summary: The National Cooperative Transplantation Study. Report BHARC-100-91-020. Seattle, WA: Battelle-Seattle Research Center, 1991.

    Google Scholar 

  40. Division of Organ Transplantation, United Network for Organ Sharing. 1994 Report of Center-Specific Graft and Patient Survival Rates: Liver Data. Rockville, MD: Health Resources and Services Administration, 1994.

    Google Scholar 

  41. Evans RW. Health care technology and the inevitability of resource allocation and rationing decisions, Part I. JAMA 1983; 249: 2047–2053.

    Article  PubMed  CAS  Google Scholar 

  42. Evans RW. Health care technology and the inevitability of resource allocation and rationing decisions, Part II. JAMA 1983; 249: 2208–2219.

    Article  PubMed  CAS  Google Scholar 

  43. Evans RW. Advanced medical technology and elderly people. In: Binstock RH, Post SG (eds.), Too Old for Health Care? Controversies in Medicine, Law, Economics, and Ethics. Baltimore, MD: The Johns Hopkins University Press, 1991: 44–74.

    Google Scholar 

  44. Evans RW. Rationale for rationing. Health Management Quarterly 1992; 14: 14–17.

    PubMed  CAS  Google Scholar 

  45. Smith R. Rationing in Action. London: BMJ Publishing Group. 1993

    Google Scholar 

  46. Bowling A, Jacobson B, Southgate L. Health service priorities: exploration in consultation of the public and health professionals on priority setting in an inner London health district. Soc. Sci. Med. 1993; 37: 851–857.

    Article  PubMed  CAS  Google Scholar 

  47. Heginbotham C. Health care priority setting: a survey of doctors, managers, and the general public. In: Smith R (ed.), Rationing In Action. London: BMJ Publishing Group, 1993: 141–156.

    Google Scholar 

  48. Ham C. Health care rationing. Br. Med. J. 1995; 310: 1483–1484.

    CAS  Google Scholar 

  49. Smith R. Being creative about rationing. Br. Med. J. 1996; 312: 391–392.

    CAS  Google Scholar 

  50. Bowling A. Health care rationing: the public’s debate. Br. Med. J. 1996; 312: 670–674.

    CAS  Google Scholar 

  51. Maynard A. Rationing health care. Br. Med. J. 1996; 313: 1499.

    CAS  Google Scholar 

  52. Klein R. Defining a package of healthcare services the NHS is responsible for: the case against. Br. Med. J. 1997; 314: 506–509.

    CAS  Google Scholar 

  53. New B. Defining a package of healthcare services the NHS is responsible for: the case for. Br. Med. J. 1997; 314: 503–505.

    CAS  Google Scholar 

  54. Kmietowciz Z. Rationing is now accepted as inevitable by all sides. Br. Med. J. 1997; 314: 461.

    Google Scholar 

  55. Harrison S. Central government should have a greater role in rationing decisions: the case against. Br. Med. J. 1997; 314: 970–973.

    CAS  Google Scholar 

  56. Lenaghan J. Central government should have a greater role in rationing decisions: the case for. Br. Med. J. 1997; 314: 967–970.

    CAS  Google Scholar 

  57. Doyal L. Rationing within the NHS should be explicit: the case for. Br. Med. J. 1997; 314: 1114–1118.

    CAS  Google Scholar 

  58. Coast J. Rationing within the NHS should be explicit: the case against. Br. Med. J. 1997; 314: 1118–1122.

    CAS  Google Scholar 

  59. Iglehart JK. The American health care system: managed care. N. Engl. J. Med. 1992; 327: 742–747.

    Article  PubMed  CAS  Google Scholar 

  60. Iglehart JK. Physicians and the growth of managed care. N. Engl. J. Med. 1994; 331: 1167–1171.

    Article  PubMed  CAS  Google Scholar 

  61. Iglehart JK. The struggle between managed care and fee-for-service practice. N. Engl. J. Med. 1994; 331: 63–67.

    Article  PubMed  CAS  Google Scholar 

  62. Jolt H, Leibovici MM. Managed Care: Principles and Practice. Philadelphia, PA: Hanley & Belfus, 1995.

    Google Scholar 

  63. Kassirer JP. Is managed care here to stay? N. Engl. J. Med. 1997; 336: 1013–1014.

    Article  PubMed  CAS  Google Scholar 

  64. Jensen GA, Morrisey MA, Gaffney S, Liston DK. The new dominance of managed care: insurance trends in the 1990s. Health Aff. 1997; 16: 125–136.

    Article  CAS  Google Scholar 

  65. Chernew M, Fendrick AM, Hirth RA. Managed care and medical technology: implications for cost growth. Health Aff. 1997; 16: 196–206.

    Article  CAS  Google Scholar 

  66. Herzlinger RE. Market-driven health care: who wins, who loses in the transformation of America’s largest service industry. Reading: Addison-Wesley, 1997.

    Google Scholar 

  67. Wilkerson JD, Devers KJ, Given R. Competitive Managed Care: The Emerging Health Care System. San Francisco: Jossey-Boss, 1997

    Google Scholar 

  68. Reiser SJ. Medicine and public health: pursuing a common destiny. JAMA 1996; 276: 1429–1430.

    Article  PubMed  CAS  Google Scholar 

  69. Hearn W. Time for medicine, public health to join forces. Am. Med. News. 1996; 39: 3.

    Google Scholar 

  70. Stapleton S. Linking medicine, public health. Am. Med. News 1997; 40: 3.

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Kluwer Academic Publishers

About this chapter

Cite this chapter

Evans, R.W., Kitzmann, D.J. (1997). Retransplantation: is the trouble worth the effort?. In: Retransplantation. Transplantation and Clinical Immunology, vol 29. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-38142-8_33

Download citation

  • DOI: https://doi.org/10.1007/978-0-585-38142-8_33

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-4937-2

  • Online ISBN: 978-0-585-38142-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics